Citation Tools

Download PDFPDF
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study

Download to a citation manager

Cite this article as:
Mrak D, Simader E, Sieghart D, et al
Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study